Chronic Myeloid Leukemia (CML) is not just a diagnosis; it is a lifelong journey that requires proactive management and emotional resilience. Comprising about 15% of all leukemia cases, CML affects the bone marrow, leading to the uncontrolled growth of white blood cells. While a cancer diagnosis can initially seem daunting, it is important to recognize that CML is manageable with the right approach.
Dr. Arijit Nag, Consultant Department of Clinical Hematology and Cellular Therapies, Tata Medical Center, Kolkata, said “In my experience I have witnessed almost 80% patients witness extreme emotional distress on initial diagnosis of CML. Despite the challenges, many patients with CML lead fulfilling lives, especially when diagnosed in the chronic phase where the disease is more manageable. However, it’s essential to remain vigilant and proactive in managing CML, as untreated chronic phase CML can progress within a few years. Monitoring your BCR-ABL levels regularly and adhering to treatment goals are key in ensuring the effectiveness of your treatment and preventing disease progression. Additionally, counselling plays a crucial role in helping patients cope with the emotional and psychological challenges of living with a chronic illness. Furthermore, discussing advances in therapies with your doctor can help you understand the treatment journey and achieve a better quality of life.”
Although CML is often termed a ‘good cancer’ because it is manageable, it is important to know that as CML progresses, it stops being ‘good.’ Some patients may become resistant to medications or experience side effects that impact their daily lives. However, timely interventions and careful monitoring can help avoid or manage these challenges. This is why, effective communication with healthcare providers ensures optimal management and instills a sense of hope and confidence in the treatment journey.
